Balaxi Pharma reports 23 per cent growth YoY during Q2FY23 EP News Bureau Nov 8, 2022 Pharma revenue up 50 per cent with expanding contribution from Latin America
Balaxi Pharma revenue grows 42 per cent in Q1 FY23 EP News Bureau Aug 3, 2022 Profit After Tax (PAT) up 32 per cent YoY
